RXRX: Pendapatan dodolan perusahaan Recursion Pharmaceuticals Inc

Aggressive hiring of Deep Learning specialists and bioinformaticians ensures Recursion Pharmaceuticals (RXRX) maintains its R&D leadership. The company dictates pricing power to Big Pharma thanks to its unique AI biology map. The company's sales volume dynamics in the GURU.Markets terminal contain a parameter that has settled at 0.07. Silicon Valley visionaries, attracted by stock options and the digitalization of medicine, support the project's success.

RXRX (Recursion Corp) riwayat Pendapatan lan volume dodolan saka 04.07.2022 nganti 13.11.2026

Rincian analitis perusahaan Recursion Pharmaceuticals

- rega saiki lan proyeksi nilai saham:

Kurs saham recursion.com|RXRX - Target konsensus

- informasi kapitalisasi pasar:

Nilai pasar Recursion Pharmaceuticals, Inc.|RXRX - Nilai Total Perusahaan

- indikator nilai aset resik miturut neraca:

Nilai Buku Saham Recursion|RXRX - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku recursion.com|RXRX - Total Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Total Utang marang Modal Recursion Pharmaceuticals|RXRX - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Recursion Pharmaceuticals Inc|RXRX - Utang perusahaan|Utang marang nilai buku Recursion Pharmaceuticals, Inc.|RXRX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Recursion|Indikator likuiditas cepet recursion.com

- indikator pendapatan resik lan kelipatan nilai:

RXRX - Bathi resik|Bathi resik sing dikarepake Recursion Pharmaceuticals|RXRX - Koefisien rega marang bathi|Pangali Forward P/E Recursion Pharmaceuticals|RXRX - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Recursion Pharmaceuticals, Inc.|RXRX - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Recursion|RXRX - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan recursion.com|RXRX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Recursion Pharmaceuticals

- statistik dodolan lan pendapatan perusahaan:

RXRX - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Recursion Pharmaceuticals, Inc.|RXRX - Rasio rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Recursion Pharmaceuticals, Inc.

Analisis komprehensif perusahaan:RXRX Recursion Corp

Barang utama Recursion Pharmaceuticals, Inc.

This metric measures total cash inflow from core operations, allowing for an assessment of the real purchasing power of revenue adjusted for inflationary pressure. By analyzing the product sales revenue of Recursion Pharmaceuticals (RXRX), an investor can confirm the operational resilience of Recursion Pharmaceuticals through the growth of milestone payments from NVIDIA and Roche, which validates the commercial viability of their AI models.

Pesaing wigati